Healthcare -
Biotechnology - NASDAQ - US
$ 0.3425
-5.66 %
$ 21.3 M
Market Cap
-0.32
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Passage Bio, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 65.2 M |
| Operating Income | -70.4 M |
| Other Expenses | -5.63 M |
| Net Income | -64.8 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 3.7 | 3.7 | 1.5 | 0.8 | 0.1 | 0 |
| Gross Profit | 0 | (3.7) | (3.7) | (1.5) | (0.8) | (0.1) | 0 |
| OPERATING INCOME | |||||||
| Operating Expenses | 65.2 | 108.4 | 135.4 | 177.7 | 111.9 | 36.7 | 10.1 |
| Selling, General and Administrative Expenses | 25.0 | 41.6 | 49.3 | 60.1 | 30.1 | 7.0 | 0.9 |
| Research and Development Expenses | 40.2 | 61.4 | 86.1 | 117.7 | 81.8 | 29.7 | 9.2 |
| Operating Income | (70.4) | (108.4) | (138.4) | (185.7) | (112.9) | (37.2) | (13.5) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0 | 2.3 | 0 | 0 | 0 | 0 |
| Total Other Income | 5.6 | 6.3 | 2.3 | 0.3 | 0.7 | (8.4) | 0.7 |
| Pre-Tax Income | (64.8) | (102.1) | (136.1) | (185.4) | (112.2) | (45.6) | (12.8) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0 | 0.7 | 6.1 | (0.5) | 8.9 | (0.7) |
| Net Income | (64.8) | (102.1) | (136.9) | (191.5) | (111.8) | (54.6) | (12.8) |
| EPS | 1.07 | 1.86 | 2.51 | 3.59 | 2.89 | 1.19 | 0.53 |